Picard Medical (PMI) Return on Invested Capital (2025 - 2026)

Picard Medical (PMI) posted Return on Invested Capital of 0.12% for Q1 2026, up 87.03% on a QoQ basis from 0.9% in Q4 2025.

Picard Medical (PMI) Return on Invested Capital (2025 - 2026) Analysis & Trends

Picard Medical's Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.12% for Q1 2026.

Quarterly Return on Invested Capital changed N/A year-over-year to 0.12% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.12% (changed N/A YoY) and the FY2025 annual result came in at 1.56%, changed N/A from the prior year.
Return on Invested Capital was 0.12% for Q1 2026 at Picard Medical, up from 0.9% in the prior quarter.
Across five years, Return on Invested Capital topped out at 0.12% in Q1 2026 and bottomed at 1.57% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	0.01%
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	0.01%
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	0.01%
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	0.00%
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	-
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	0.00%
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	0.00%
10	Picard Medical	6.70 Mn	6.70 Mn	275,000.00	-0.12%

Download Data